Pharmaceutical companies are turning to their medical affairs function to boost interactions with critical payer groups such as Accountable Care Organizations and Integrated Delivery Networks. As value-based drug contracting between manufacturers and payers continue to move forward, and the healthcare industry turns away from fee-for-service, public and private payers are pushing providers to take on more financial accountability for their services through alternative payment models.
The 11th Partnering with ACOs & IDNs Summit will provide a platform for collaboration to advance ACO, IDN, and life sciences partnerships in population health management. Methods of information-exchange will include detailed presentations, collaborative panel discussions, and an interactive dinner.
![]() |
Stephanie Roberts, Corporate Account Director, ACORDA THERAPEUTICS |
![]() |
CORRELATE VALUE-BASED PERFORMANCE OF IDN AND ACO MODELS TO THE MEDICARE IMPERATIVES John Sears, Ph.D., MBA, Health Care Quality and Commercial Strategy Director, JOHNSON & JOHNSON |
![]() |
SHARE OF VOICE TO SYSTEM-FOCUSED Matt Portch, Vice President, Managed Markets, SUNOVION |
![]() |
PHARMACEUTICALS TAKE ON RISK DURING HEALTHCARE TRANSFORMATION Michael Hunt, CEO/President, ST. VINCENT’S HEALTH PARTNERS |
![]() HEALTHCARE EXECUTIVE THINK TANKMeet directly with executives from ACOs and IDNs to enable the implementation of collaborative partnerships |
![]() EXECUTIVE PAYER ASSEMBLYThe Executive Payer Assembly is your opportunity to hear from eight-payer executives discuss needs, expectations, and preferred operations for value-based contracting |
![]() |
![]() |
![]() |
![]() |
Steven Peskin, Healthcare Delivery Innovation, HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY |
Mark Fisher, Senior Manager, Organized Customer Group Commercial Excellence, SANOFI |
Sarah Johnson Conway, M.D., Associate Medical Director, JOHNS HOPKINS MEDICINE ALLIANCE FOR PATIENTS (JMAP) |
Jesse Fishman, Health Outcomes Lead, Medical Affairs Professional, UCB |
This event is ideal for professionals from payers and pharmaceutical, biotechnology and medical device companies with responsibilities in the following areas:
|
|
This conference is also of interest to:
|
|